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E-mail address: jin@tohoku-pharm.ac.jp (J.-i. InokuPreviously, we demonstrated that an inhibitor of ganglioside biosynthesis, D-PDMP, could restore
impaired insulin signaling in tumor necrosis factor a (TNFa)-treated adipocytes by blocking the
increase of GM3 ganglioside. Here, we analyzed the interaction between insulin receptor (IR) and
GM3 in the plasma membranes using immunoelectron microscopy. In normal adipocytes, most
GM3 molecules localized at planar and non-caveolar regions. Approximately 19% of IR molecules
were detected in caveolar regions. The relative ratio of IRs associated with caveolae in TNFa-treated
adipocytes was decreased to one-ﬁfth of that in normal adipocytes, but this decrease was restored
by D-PDMP. Thus, we could obtain direct evidence that insulin resistance is a membrane microdo-
main disorder caused by aberrant expression of ganglioside.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Obesity, insulin resistance, and type 2 diabetes are closely asso-
ciated with chronic inﬂammation, which is characterized by abnor-
mal cytokine production [1]. Tumor necrosis factor a (TNFa) is a
proinﬂammatory cytokine that is overexpressed in adipose and
other tissues in experimental mouse models of obesity and in hu-
mans. TNFa activates various signal transduction cascades, which
inhibit insulin actions [2]. In obese mouse models, a lack of TNFa
function results in improved insulin sensitivity and glucose homeo-
stasis, conﬁrming that this inﬂammatory pathway plays a critical
role in the regulation of insulin action in obesity [3]. Macrophage
inﬁltration of adipose tissue has recently been described in obese
conditions [4]. It has been suggested that expanding adipocytes or
neighboring preadipocytes might initiate the production of chemo-
tactic signals, leading to macrophage recruitment. Inﬁltrating mac-
rophages appear to be responsible for TNFa secretion in adipose
tissue [5]. Further, adipose tissue only accounts for 10% of insu-
lin-stimulated whole body glucose uptake [6]. Decreased insulin
sensitivity of adipose cells leads to an increased release of free fattychemical Societies. Published by E
chi).acids (FFAs) into the systemic circulation, which contributes to he-
patic and muscle insulin resistance [7–9].
Gangliosides, which bear sialic acid residues, exist ubiquitously
in the outer leaﬂet of vertebrate plasma membranes. GM3 is the
most abundant and primary ganglioside found in adipocytes [10].
GM3 spontaneously forms clusters with its own saturated fatty acyl
chains, in spite of the negatively charged sugar chains [11]. Previ-
ously, we found that GM3 was signiﬁcantly up-regulated in 3T3-
L1 adipocytes when the cells were treated with TNFa to induce a
state of insulin resistance [12]. Moreover, pharmacological inhibi-
tion of GM3 biosynthesis by an inhibitor of glucosylceramide
synthase (D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-pro-
panol; D-PDMP) [13], was able to normalize the impaired insulin sig-
naling of TNFa-treated adipocytes [12]. In normal adipocytes, insulin
receptors (IRs) are concentrated in detergent-resistant membrane
microdomains (DRMs), which also contain caveolin-1 (Cav1) [14].
Treatment of adipocytes with TNFa resulted in the elimination of
the majority of IRs from DRMs; however, D-PDMP treatment pre-
vented this elimination [14]. Since GM3 is an important component
of certain membrane microdomain lipid rafts, we propose a new
pathological view of insulin resistance, namely, that insulin resis-
tance is a membrane microdomain disorder [15].
It is well known that Cav1 promotes tyrosine kinase activity of
IRs [16,17]. Therefore, dissociation of IRs from DRMs should resultlsevier B.V. All rights reserved.
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ity. The ability of D-PDMP to prevent dissociation of IRs suggests a
physical interaction between GM3 and Cav1, or GM3 and IRs. In co-
immunoprecipitation experiments, both Cav1 and GM3 co-precip-
itated with IRs; however, Cav1 did not co-precipitate with GM3,
indicating that IRs bind Cav1 and GM3 independently [14]. Based
on these results, we speculated that TNFa induces a state of insulin
resistance in adipocytes by up-regulating GM3, which inhibits the
interaction of IR and Cav1 [15].
Biochemical isolation of microdomains using detergents limits
the ability of researchers to identify the precise location of IRs in
the plasma membrane, as the number of IRs in DRMs is greatly
inﬂuenced by the concentration of the detergent used, such as Tri-
ton-X 100 [14,18]. Therefore, in order to determine the true mobile
behavior of IRs, we developed a live cell imaging system to visual-
ize IRs and Cav1, using total internal reﬂection ﬂuorescence
microscopy (TIR-FM) and ﬂuorescence recovery after photobleach-
ing (FRAP) [15].
Using TIR-FM, we conﬁrmed that most Cav1-GFP molecules ex-
pressed in HEK293 cells were static, indicating that they were res-
idents of Cav1-rich microdomains, termed caveolae. In contrast,
nearly 50% of the IR-GFP molecules exhibited rapid lateral move-
ment, indicating that IR proteins are resident in both mobile and
immobile fractions of the plasma membrane. The immobile nature
of some IRs is likely due to their interaction with Cav1. To verify
this, we used a FRAP technique to measure the mobility of IR and
Cav1 at the plasma membrane in living cells. The FRAP of IR-
GFP-expressing HEK293 cells was considerably faster than cells
co-expressing IR-GFP and Cav1-RFP, demonstrating the immobili-
zation of some IRs through their interaction with Cav1 in living
cells [15].
We also examined IR mobility in the plasma membranes of
GM3-reconstituted [GM3 (+)] cells by mock transfecting [GM3
()] or transfecting the GM3 synthase (SAT-I) gene into GM3-deﬁ-
cient cells expressing equal levels of Cav1 [15]. The mobility of IR-
GFP expressed in GM3 (+) cells was signiﬁcantly higher than that in
GM3 () cells. These results strongly suggested that GM3 is able to
enhance IR mobility by dissociating Cav1-IR complexes in living
cells. The GM3-induced dissociation of the IR-Cav1 complex during
states of insulin resistance was shown to be due to an electrostatic
interaction between Lys944 in the IRb subunit and the sialic acid of
GM3 [15]. Thus, our previous observations strongly suggest the
presence of distinct membrane subdomains, including caveolae
harboring IR-Cav1 complexes and another subdomains containing
IR-GM3 complexes.
The precise location of IRs in the plasma membrane, including
caveolae, remains unknown. To determine whether IRs translocate
from the caveolae to GM3-enriched membrane microdomains in
adipocytes during states of insulin resistance [15], we used immu-
noelectron microscopy to observe the movement of IRs, Cav1, and
GM3 using 3T3-L1 adipocytes.2. Materials and methods
2.1. Specimens
Murine 3T3-L1 preadipocytes were cultured, maintained, and
differentiated, as described previously [12]. For insulin studies,
cells were stimulated with 100 nM insulin for 15 min. Rat TNFa
was dissolved in phosphate-buffered saline (PBS) containing 0.1%
fatty acid-free, growth factor depleted bovine serum albumin
(BSA; Sigma-Aldrich, MO, USA). The TNFa solution was added di-
rectly to the cell culture media at a concentration of 100 pM and
maintained for 96 h. Cellular glycosphingolipids (including GM3)
were depleted by the addition of 20 lM D-PDMP, an inhibitor ofglucosylceramide synthase, which was synthesized as described
previously [13].
2.2. Specimen preparation for immunoelectron microscopy (GM3
labeling)
3T3-L1 adipocytes were transferred onto plastic sheets (Cell-
desk LF; Sumitomo Bakelite Co., Ltd., Tokyo, Japan) and ﬁxed in
4% paraformaldehyde (diluted in 0.1 M PBS) for 2 h at 4 C. Cells
were then incubated with anti-GM3 (clone GMR6; Seikagaku Bio-
business Corp., Tokyo, Japan) diluted 1:30 in PBS for 2 h at 4 C.
After further incubation with rabbit anti-mouse IgM (clone
M8644; Sigma-Aldrich) diluted 1:30 in PBS for 2 h at 4 C, cells
were ﬁxed with 1% glutaraldehyde in PBS for 1 h at 4 C. Cells were
then extensively washed and then labeled with 15 nm gold parti-
cles conjugated to protein A (BBInternational, Cardiff, UK) diluted
1:30 in PBS for 2 h at room temperature (RT). Control experiments
were performed in tandem by omitting anti-GM3 from the immu-
nolabeling procedure. All specimens were post-ﬁxed in 1% osmium
tetroxide with 1.5% potassium ferrocyanide buffered with 0.1 M
cacodylate for 1 h at 4 C and dehydrated with a 50–100% ethanol
series. Propylene oxide was then added and the specimens were
inﬁltrated with epoxy resin. Resin-embedded specimens were
polymerized in an electric oven at 60 C for 48 h, sectioned and
treated with lead citrate solution for 3 min.
2.3. Specimen preparation for immunoelectron microscopy (Cav1 and
IRb labeling)
The preparation of plasma membrane sheets was performed as
previously described [19,20], with minor modiﬁcations. Brieﬂy,
nickel specimen grids were processed in sequence, using formvar
and carbon coating, ion etching, and a 0.1 mg/mL poly-L-lysine
(Sigma-Aldrich) coating treatment. Prepared nickel grids were
placed onto exposed 3T3-L1 cells with their coated side face-down
for 1 min. The grids contacted and stuck to the plasma membranes
along the apical face of the cells, and then the grids were ﬂoated
with ﬁxative (4% paraformaldehyde and 0.05% glutaraldehyde di-
luted in 0.1 M PBS). The plasma membranes were ﬁxed for 1 h at
4 C. The plasma membrane sheets were incubated with 4 lg/mL
rabbit anti-IRb (clone C19; Santa Cruz Biotechnology, Inc., Santa
Cruz, CA, USA) or 1 lg/mL anti-Cav1 (clone N20; Santa Cruz Bio-
technology, Inc.) for 2 h at 4 C and then labeled with 12 nm gold
particles conjugated to 1:30 goat anti-rabbit IgG (Jackson Immuno-
Research Lab, Inc., PA, USA) for 2 h at RT. After extensive washing
with PBS, specimens were ﬁxed with 2.5% glutaraldehyde in
0.1 M PBS at 4 C for 1 h, followed by 1% osmium tetroxide with
1.5% potassium ferrocyanide buffered with 0.1 M cacodylate at
4 C for 1 h, and then stained with uranyl acetate for 10 min at
RT. Next, specimens are dehydrated with a 50–100% ethanol series
plus 99% t-butyl alcohol twice for 10 min. Finally, specimens were
freeze-dried in a freeze-dryer (FDU-2200; Tokyo Rikakikai. Co.,
Ltd., Tokyo, Japan).
2.4. Electron microscopy and data analysis
Specimens were observed with a transmission electron micro-
scope (JEM-1010; JEOL, Ltd., Tokyo, Japan) and photographed at
20000magniﬁcation. Gold particles were counted and their loca-
tions, i.e., in caveolae or non-caveolar areas, were noted. Gold par-
ticles in unidentiﬁed aggregations were excluded from the
analysis. The indirect immunogold labeling technique typically
causes gaps between the actual location of an antigen and the gold
particles, due to the presence of immunoglobulin molecules within
the gaps [21]. With this in mind, our immunogold electron micro-
scopic analysis categorized gold particles labeled with anti-
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lae-associated IRs. Similarly, gold particles labeled with protein
A-anti-IgM(IgG)-anti-GM3(IgM) located within 30 nm of caveolae
were categorized as caveolae-associated GM3.
Plasma membrane areas (lm2) observed in each photograph
were measured with ImageJ software (http://rsb.info.nih.gov/ij/),
and the ratio of the number of gold particles within caveolae to
the plasma membrane area (number of particles/lm2) was calcu-
lated. Finally, signiﬁcant differences (p-value <0.01) between the
ratios of non-treated versus TNFa-treated specimens and between
the ratios of TNFa-treated versus TNFa-plus D-PDMP-treated spec-
imens, were determined by Student’s t-tests.
3. Results
3.1. Distribution of GM3 within the plasma membrane of 3T3-L1
adipocytes
Immunoelectron microscopy using gold particle labeling re-
vealed an uneven distribution of GM3 along the plasma membrane
of 3T3-L1 adipocytes (Fig. 1A). Plasma membrane invaginations
with diameters of 50–80 nmwere detected, which is the character-
istic shape of caveolae (Fig. 1B). A comparison of the number of
gold particle-labeled GM3 molecules in caveolae versus those in
non-caveolar areas determined that 85% were present outside of
caveolae (Fig. 1C).
3.2. Distribution of Cav1 and IR within the plasma membrane of 3T3-
L1 adipocytes
The distribution of Cav1 and IRs in the plasma membrane of
3T3-L1 adipocytes was examined by immunoelectron microscopy
of untreated cells. Apical plasmamembranes were adhered to nick-
el specimen grids, with the cytoplasmic face of membrane
exposed, and labeled with rabbit polyclonal antibodies against
the C-terminus of IRs (Fig. 2A) or Cav1 (Fig. 2B), followed by
gold-conjugated goat anti-rabbit IgG. Cav1 molecules, and their
associated gold particles, were speciﬁcally localized near or along
the outer edge of caveolae. IR-labeled membranes indicated that
IRs were predominantly located in the planar part of the plasma
membrane (Fig. 2A, solid-lined circles), with some near the caveo-
lae (Fig. 2A, dot-lined circles). The ratio of the number of IRs in the
caveolae area (within 20 nm of caveolae) to the number of total IRs
was 33% in untreated adipocytes. Treatment of the cells withFig. 1. Immunoelectron microscopy of GM3molecules labeled with gold particles. (A) Inv
molecules were detected. (B) Gold particles are located near caveolae, although not in ca
those in non-caveolar areas. Gold-labeled GM3 located within 30 nm of caveolae were d
GM3.100 nM insulin for 15 min decreased the ratio to 17%. The
mean ± standard error (SE) density of total gold-labeled IRs in un-
treated adipocytes was 1.44 ± 0.20 gold particles/lm2 membrane
as compared with the background labeling of 0.13 ± 0.05 gold par-
ticles/lm2 membrane.
We next determined the effects of TNFa- and D-PDMP-treat-
ment on the distribution of IRs in relation to caveolae (Fig. 3).
The number of IRs located in caveolae areas in untreated cells
(), TNFa-treated cells (T), and TNFa plus D-PDMP-treated cells
(T + D) were counted and compared by a Student’s t-test. There
were more gold-labeled IRs in caveolae areas in () cells than in
(T) cells, while there were fewer IRs in (T) cells than in (T + D) cells.
Experiments using mouse monoclonal anti-IRb antibodies showed
similar results (data not shown).
4. Discussion
Our laboratory has been investigating the mechanism by which
GM3 inhibits insulin signaling [12,14,15]. In previous studies, we
found a signiﬁcant increase in cellular GM3 in 3T3-L1 adipocytes
during TNFa-induced insulin resistance. In addition, live cell stud-
ies of real-time lateral interactions between IR, Cav1, and GM3 at
the adipocyte plasma membrane, as well as related biochemical
studies, strongly suggested the dynamic translocation of IR from
caveolar microdomains into GM3-rich microdomains during states
of insulin resistance.
In the present study, immunoelectron microscopic analyses of
the distribution of IR, Cav1, and GM3 in the plasma membrane of
3T3-L1 adipocytes was conducted under normal conditions and
in states of TNFa-induced insulin resistance, with or without D-
PDMP treatment. We found that (i) the number of IRs in caveolar
regions decreased signiﬁcantly in TNFa-treated adipocytes as com-
pared with untreated cells and (ii) the decreased number of IRs in
the caveolar regions of TNFa-treated cells was mostly restored
upon treatment with D-PDMP.
The distribution of GM3 in plasma membranes has been studied
by immunoelectron microscopy in ﬁbroblasts, lymphocytes, and
MDCK II cells [22–24]. In this study, we investigated the distribu-
tion of GM3 in 3T3-L1 adipocytes. In order to observe the localiza-
tion of lipids by immunoelectron microscopy, special techniques,
such as the quick-freezing and freeze-fracture method developed
by Fujimoto et al. [25], are required. In addition, it was recently
shown that lipids cannot be ﬁxed with glutaraldehyde in typical
immunoelectron microscopy assays [26]. In our study, it isaginations of the plasma membrane (;) indicate caveolae. Cluster formations of GM3
veolae. (C) The ratio of the number of gold particle-labeled GM3 in caveolar areas to
eﬁned as caveolae-associated GM3 and the others were designated as non-caveolar
Fig. 2. Distribution of IR and caveolin-1 (Cav1) in adipocyte plasma membranes. (A) Immunogold electron microscopy shows that the majority of IRs are located in the planar
regions of the adipocyte plasma membrane. The electron micrograph shows a view of the cytoplasmic face of the adipocyte plasma membrane, immunogold-labeled with
anti-IRb. Some gold particles are located in the planar part of the membrane (solid-lined circles). Caveolae, clustered or single, also contain some gold particles (dot-lined
circles). (B) Analogously prepared adipocyte membrane, immunogold-labeled with anti-Cav1. Caveolae are speciﬁcally labeled with gold particles. (C) Higher magniﬁcation
view of caveolae and gold-labeled IRs. (D) Number of gold-labeled IRs on the adipocyte membrane. Approximately 33% of the IRs localized to deﬁned caveolar areas in
untreated cells; however, insulin treatment decreased this ratio to 17%. Specimens were positively stained with osmium tetroxide, tannic acid, and uranyl acetate. Scale bars,
100 nm.
Fig. 3. The density of IR molecules in caveolar regions in untreated, TNFa-treated,
and TNFa plus D-PDMP-treated 3T3-L1 cells. Gold-labeled IR molecules that
localized to within 20 nm of caveolae were deﬁned as caveolae-associated IR and
all others were designated ﬂat-membrane localized IR. The total number of gold
particles was 750. The total number of images taken was 41. The total area of the
plasma membrane, excluding aggregates of miscellaneous cell structures, was
measured and used for calculating the mean density of gold-labeled IRs in the
caveolae of each specimen. ⁄p < 0.01.
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lipid-enriched microdomains or were an artifact of the addition of
anti-GM3 antibody. Nevertheless, if GM3 localized to caveolae, the
associated gold particles would have also localized near the cave-
olae, regardless of the presence of GM3 clusters. We detected
few gold-labeled GM3 particles in caveolae, and the ratio of GM3in caveolar regions was 15% of total GM3 molecules. Many GM3
molecules localized to non-caveolar areas, indicating that GM3
does not accumulate in caveolae.
IR contains a caveolin binding motif, which allows it to interact
with caveolins, transmitting insulin metabolic signals into the cell
[27]. While some immunoelectron microscopy studies detected
co-localization of caveolae and IRs [28,29], others did not [30].
One group suggested that these apparently contradictory results
were the result of biochemical differences between the neck and
bulb portions of caveolae [31], but this hypothesis is yet to be ver-
iﬁed. In our study, many gold-labeled IRs were observed in mem-
brane areas outside of the caveolae and only some IRs (33% in
normal cells and 17% in insulin-treated cells) were present in de-
ﬁned caveolae. The decreasing ratio of caveolae-resident IRs to to-
tal IRs in insulin-treated cells could be attributed to endocytosis of
IRs that bound insulin at the plasma membrane [32,33]. The obser-
vation that the majority of IRs resided outside of caveolar regions
suggests that it is not necessary for IRs to stably exist within cav-
eolae for the successful insulin signaling. It is known that IRs
dynamically traverse the plasma membrane [15], enabling them
to regularly interact with caveolae and transmit signals. These
observations are is supported by a study showing that maximum
insulin signals can occur after activation of just 3% of total IRs
[34]. As demonstrated in our previous work [12,14,15] and Fig. 3
in this paper, TNFa treatment of 3T3-L1 cells induced insulin resis-
tance and signiﬁcantly reduced the number of IRs bound to caveo-
lae with concomitant increase of GM3 in adipocytes. Furthermore,
D-PDMP treatment to block the elevation of GM3 normalizes the
suppressed-insulin signaling in TNFa-treated adipocytes. Taken to-
gether, our data demonstrate that insulin resistance develops due
J. Sekimoto et al. / FEBS Letters 586 (2012) 191–195 195to the inhibition of caveolae-IR interactions by the concomitant in-
crease of GM3 in adipocytes.
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